These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 8372434)

  • 1. Moloney murine leukemia virus protease: bacterial expression and characterization of the purified enzyme.
    Menéndez-Arias L; Gotte D; Oroszlan S
    Virology; 1993 Oct; 196(2):557-63. PubMed ID: 8372434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Naturally occurring amino acid polymorphisms in human immunodeficiency virus type 1 (HIV-1) Gag p7(NC) and the C-cleavage site impact Gag-Pol processing by HIV-1 protease.
    Goodenow MM; Bloom G; Rose SL; Pomeroy SM; O'Brien PO; Perez EE; Sleasman JW; Dunn BM
    Virology; 2002 Jan; 292(1):137-49. PubMed ID: 11878916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The 80's loop (residues 78 to 85) is important for the differential activity of retroviral proteases.
    Stebbins J; Towler EM; Tennant MG; Deckman IC; Debouck C
    J Mol Biol; 1997 Apr; 267(3):467-75. PubMed ID: 9126830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and purification of active form of HIV-1 protease from E.coli.
    Wan M; Loh BN
    Biochem Mol Biol Int; 1995 Apr; 35(4):899-912. PubMed ID: 7627139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural variation in HIV-1 protease, Gag p7 and p6, and protease cleavage sites within gag/pol polyproteins: amino acid substitutions in the absence of protease inhibitors in mothers and children infected by human immunodeficiency virus type 1.
    Barrie KA; Perez EE; Lamers SL; Farmerie WG; Dunn BM; Sleasman JW; Goodenow MM
    Virology; 1996 May; 219(2):407-16. PubMed ID: 8638406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of retroviral protease activity by an aspartyl proteinase inhibitor.
    Katoh I; Yasunaga T; Ikawa Y; Yoshinaka Y
    Nature; 1987 Oct 15-21; 329(6140):654-6. PubMed ID: 2821409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteolytic activity of human immunodeficiency virus Vpr- and Vpx-protease fusion proteins.
    Wu X; Liu H; Xiao H; Kappes JC
    Virology; 1996 May; 219(1):307-13. PubMed ID: 8623547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The virion-associated Gag-Pol is decreased in chimeric Moloney murine leukemia viruses in which the readthrough region is replaced by the frameshift region of the human immunodeficiency virus type 1.
    Gendron K; Dulude D; Lemay G; Ferbeyre G; Brakier-Gingras L
    Virology; 2005 Apr; 334(2):342-52. PubMed ID: 15780884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and molecular characterization of an enzymatically active recombinant human spumaretrovirus protease.
    Pfrepper KI; Löchelt M; Schnölzer M; Flügel RM
    Biochem Biophys Res Commun; 1997 Aug; 237(3):548-53. PubMed ID: 9299401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Substrates and inhibitors of human T-cell leukemia virus type I protease.
    Ding YS; Rich DH; Ikeda RA
    Biochemistry; 1998 Dec; 37(50):17514-8. PubMed ID: 9860866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of the murine leukemia virus protease in fusion with maltose-binding protein in Escherichia coli.
    Fehér A; Boross P; Sperka T; Oroszlan S; Tözsér J
    Protein Expr Purif; 2004 May; 35(1):62-8. PubMed ID: 15039067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bovine leukemia virus: purification and characterization of the aspartic protease.
    Menard A; Mamoun RZ; Geoffre S; Castroviejo M; Raymond S; Precigoux G; Hospital M; Guillemain B
    Virology; 1993 Apr; 193(2):680-9. PubMed ID: 8384751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Point mutation in avian sarcoma leukaemia virus protease which increases its activity but impairs infectious virus production.
    Arad G; Chorev M; Shtorch A; Goldblum A; Kotler M
    J Gen Virol; 1995 Aug; 76 ( Pt 8)():1917-25. PubMed ID: 7543558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations in the protease gene of human immunodeficiency virus type 1 affect release and stability of virus particles.
    Park J; Morrow CD
    Virology; 1993 Jun; 194(2):843-50. PubMed ID: 8503189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purification and characterization of the mouse mammary tumor virus protease expressed in Escherichia coli.
    Menéndez-Arias L; Young M; Oroszlan S
    J Biol Chem; 1992 Nov; 267(33):24134-9. PubMed ID: 1331110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteolytic activity of purified avian sarcoma and leukemia virus NC-PR protein expressed in Escherichia coli.
    Séllos-Moura M; Vogt VM
    Virology; 1996 Jul; 221(2):335-45. PubMed ID: 8661444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contribution of the Gag-Pol transframe domain p6* and its coding sequence to morphogenesis and replication of human immunodeficiency virus type 1.
    Paulus C; Ludwig C; Wagner R
    Virology; 2004 Dec; 330(1):271-83. PubMed ID: 15527852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. One-step purification of plant ferredoxin-NADP+ oxidoreductase expressed in Escherichia coli as fusion with glutathione S-transferase.
    Serra EC; Carrillo N; Krapp AR; Ceccarelli EA
    Protein Expr Purif; 1993 Dec; 4(6):539-46. PubMed ID: 8286951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV protease cleaves poly(A)-binding protein.
    Alvarez E; Castelló A; Menéndez-Arias L; Carrasco L
    Biochem J; 2006 Jun; 396(2):219-26. PubMed ID: 16594896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of protein expression and virus-like particle formation in mammalian cell lines stably expressing HIV-1 gag and env gene products with or without active HIV proteinase.
    Kräusslich HG; Ochsenbauer C; Traenckner AM; Mergener K; Fäcke M; Gelderblom HR; Bosch V
    Virology; 1993 Feb; 192(2):605-17. PubMed ID: 8421902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.